Cargando…

SARS-CoV-2 infection in severe pediatric Crohn's disease. What about anti-tumor necrosis factor α therapy?

Detalles Bibliográficos
Autores principales:	Bardasi, Giulia, Alvisi, Patrizia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. 2020
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7831628/ https://www.ncbi.nlm.nih.gov/pubmed/32703727 http://dx.doi.org/10.1016/j.dld.2020.06.047

Ejemplares similares

Effects of visceral adipose tissue on anti-tumour necrosis factor-α in Crohn’s disease
por: Li, Kangrong, et al.
Publicado: (2023)

An appeal for an objective, open, and transparent scientific debate about the origin of SARS-CoV-2
por: van Helden, Jacques, et al.
Publicado: (2021)

Protective humoral immunity in SARS-CoV-2 infected pediatric patients
por: Zhang, Yaguang, et al.
Publicado: (2020)

Beau‐Lines of the fingernails in association with pediatric SARS‐CoV‐2 infections
por: Wolf, Gerhard K., et al.
Publicado: (2021)

Neurologic Features in Severe SARS-CoV-2 Infection
por: Helms, Julie, et al.
Publicado: (2020)

What are we talking about when we talk about post-COVID-19?()
por: Cairoli, E.
Publicado: (2021)

Clinical update on the efficacy of anti-SARS-CoV-2 mRNA vaccines in patients on the waiting list for liver transplantation and in liver transplant recipients
por: Toniutto, Pierluigi, et al.
Publicado: (2021)

Setting-specific variability of false-positive result rates with rapid testing for SARS-CoV-2 antigen
por: Posteraro, Patrizia, et al.
Publicado: (2022)

What chikungunya teaches us about COVID-19
por: Simon, Fabrice, et al.
Publicado: (2021)

What the Placebo Tells Us about Chronic Cough
por: Weinberger, Miles
Publicado: (2023)

Subacute voluntary care provision, what about Yalom?
por: Beckmann, Klaus Martin, et al.
Publicado: (2023)

Seroconversion and dynamics of the anti-SARS-CoV-2 antibody response related to a hospital COVID-19 outbreak among pediatric oncology patients
por: Mayanskiy, Nikolay, et al.
Publicado: (2021)

Imatinib is not a potent anti-SARS-CoV-2 drug
por: Zhao, Helong, et al.
Publicado: (2020)

Estimates of anti-SARS-CoV-2 antibody seroprevalence in Iran
por: Nazemipour, Maryam, et al.
Publicado: (2021)

Estimates of anti-SARS-CoV-2 antibody seroprevalence in Iran
por: Ghafari, Mahan, et al.
Publicado: (2021)

Immunoassays for anti-SARS-CoV-2 antibodies: recent insights
por: Van Elslande, Jan, et al.
Publicado: (2021)

WHO International Standard for anti-SARS-CoV-2 immunoglobulin
por: Kristiansen, Paul A, et al.
Publicado: (2021)

Tumor necrosis factor α-induced protein 3 (A20) is dysregulated in pediatric Crohn disease
por: Zaidi, Deenaz, et al.
Publicado: (2018)

Severity of SARS-CoV-2 Reinfections as Compared with Primary Infections
por: Abu-Raddad, Laith J., et al.
Publicado: (2021)

Severity of SARS-CoV-2 Omicron XBB subvariants in Singapore
por: Pung, Rachael, et al.
Publicado: (2023)

An appeal for an objective, open, and transparent scientific debate about the origin of SARS-CoV-2 – Authors' reply
por: Keusch, Gerald T, et al.
Publicado: (2021)

Intermittent fasting on health, aging and disease: what about sleep?
por: Cruz, Miguel Meira e
Publicado: (2020)

Severe sinus bradycardia associated with Remdesivir in a child with severe SARS-CoV-2 infection
por: Sanchez-Codez, Maria Isabel, et al.
Publicado: (2021)

Estimating the risk of SARS-CoV-2 transmission to pediatric anesthesiologists: a microsimulation model
por: Aoyama, Kazuyoshi, et al.
Publicado: (2020)

Outcome of SARS-CoV-2 infection in patients with severe asthma on biologics
por: Kagohashi, Katsunori, et al.
Publicado: (2022)

Severe acute hepatitis in children: investigate SARS-CoV-2 superantigens
por: Brodin, Petter, et al.
Publicado: (2022)

Misclassification bias in estimating clinical severity of SARS-CoV-2 variants
por: Yek, Christina, et al.
Publicado: (2022)

Standardization of Reporting Criteria for Lung Pathology in SARS-CoV-2–infected Hamsters: What Matters?
por: Gruber, Achim D., et al.
Publicado: (2020)

Fecal–Oral Transmission of SARS-COV-2: Practical Implications
por: Bonato, Giulia, et al.
Publicado: (2020)

Pre-labor anorectal swab for SARS-CoV-2 in COVID-19 pregnant patients: is it time to think about it?
por: Carosso, Andrea, et al.
Publicado: (2020)

The Long-Term Effect of Early Anti-Tumor Necrosis Factor on Restoration of Growth in Pediatric Crohn’s Disease
por: Shim, Jung Ok, et al.
Publicado: (2018)

Growth and Adult Height in Patients with Crohn's Disease Treated with Anti-Tumor Necrosis Factor α Antibodies
por: Bamberger, Sarah, et al.
Publicado: (2016)

Efficacy of restarting anti-tumor necrosis factor α agents after surgery in patients with Crohn's disease
por: Hiraoka, Sakiko, et al.
Publicado: (2018)

A Series of Genes for Predicting Responses to Anti-Tumor Necrosis Factor α Therapy in Crohn’s Disease
por: Nie, Kai, et al.
Publicado: (2022)

Erratum: Correction of Notes. Safe Re-administration of Tumor Necrosis Factor-alpha (TNFα) Inhibitors in Patients with Rheumatoid Arthritis or Ankylosing Spondylitis Who Developed Active Tuberculosis on Previous Anti-TNFα Therapy
por: Suh, Young Sun, et al.
Publicado: (2014)

Estimates of anti-SARS-CoV-2 antibody seroprevalence in Iran – Authors' reply
por: Darvishian, Maryam, et al.
Publicado: (2021)

Seroprevalence of anti-SARS-CoV-2 antibodies after the second pandemic peak
por: Stringhini, Silvia, et al.
Publicado: (2021)

No crossreactivity of anti-SARS-CoV-2 spike protein antibodies with Syncytin-1
por: Prasad, Mukul, et al.
Publicado: (2021)

Specificity and cross-reactivity of a test for anti-SARS-CoV-2 antibodies
por: Choy, Kay Weng
Publicado: (2021)

‘Mind the gap’: what patients and clinicians believe is ‘unknown’ about psoriasis
por: Majeed‐Ariss, R., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_769h1e4rjkru739847qe2j8jp1